Eli Lilly (LLY) earnings

LLY earnings moved a median of +0.27% by the close. Quarterly and annual LLY reports and results, each read against the price at its own news timestamp. Back to the LLY overview →

44 measured LLY earnings events.

Where these LLY earnings landedvs 44 measured LLY earnings reactions
LLY earningsMiddle 50% · -0.73% to +0.97%Zero: 0.00%Median: +0.27%Median +0.27%-1.50%0+1.50%
Middle 50% of LLY earnings reactions-0.73% to +0.97%
Median reaction (to close)+0.27%
Measured reactions44
Point-in-time · zero look-ahead

Half of the 44 LLY earnings events with a measured close landed between -0.73% and +0.97%; 59% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q ELI LILLY & Co For: Jun 30SEC filing · Form 10-Q+0.15%+0.96%
Lilly reports second-quarter 2026 financial results, raises full-year guidance, and highlights continued growth and pipeline progressPress release+2.15%-1.59%
Lilly confirms date and conference call for second-quarter 2026 financial results announcementPress release+0.01%+0.26%
Lilly declares third-quarter 2026 dividendPress release-0.25%+0.20%
Lilly declares second-quarter 2026 dividendPress release-0.00%+0.76%
Form 10-Q ELI LILLY & Co For: Mar 31SEC filing · Form 10-Q+0.01%+1.36%
Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicinesPress release+0.60%+3.84%
Lilly confirms date and conference call for first-quarter 2026 financial results announcementPress release-0.15%-1.11%
Form 10-K ELI LILLY & Co For: Dec 31SEC filing · Form 10-K+0.06%-0.82%
Lilly reports fourth-quarter 2025 financial results and provides 2026 guidancePress release+0.26%+2.80%
Lilly confirms date and conference call for fourth-quarter 2025 financial results announcementPress release+0.20%+1.00%
Lilly declares first-quarter 2026 dividendPress release+0.16%+0.39%
Form 10-Q ELI LILLY & Co For: Sep 30SEC filing · Form 10-Q+0.45%+0.00%
Lilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidancePress release-1.72%+0.66%
Lilly declares fourth-quarter 2025 dividendPress release+0.11%+0.49%
Lilly confirms date and conference call for third-quarter 2025 financial results announcementPress release+0.05%-1.69%
Form 10-Q ELI LILLY & Co For: Jun 30SEC filing · Form 10-Q-0.90%-0.35%
Lilly reports second-quarter 2025 financial results and raises guidancePress release-2.12%-4.96%
Lilly confirms date and conference call for second-quarter 2025 financial results announcementPress release+0.15%+0.71%
Lilly declares third-quarter 2025 dividendPress release-0.10%+0.31%
Lilly declares second-quarter 2025 dividendPress release+0.17%-0.06%
Form 10-Q ELI LILLY & Co For: Mar 31SEC filing · Form 10-Q-0.23%-2.68%
Lilly reports first-quarter 2025 financial results and highlights pipeline momentumPress release-0.49%-5.91%
Lilly confirms date and conference call for first-quarter 2025 financial results announcementPress release-0.30%-0.71%
Form 10-K ELI LILLY & Co For: Dec 31SEC filing · Form 10-K-0.22%+0.29%
Lilly confirms date and conference call for fourth-quarter 2024 financial results and 2025 financial guidance announcementPress release+0.30%+2.48%
Form 10-Q ELI LILLY & Co For: Sep 30SEC filing · Form 10-Q+0.06%-0.04%
Lilly declares fourth-quarter 2024 dividendPress release+0.04%+0.24%
Lilly confirms date and conference call for third-quarter 2024 financial results announcementPress release+0.26%+1.24%
Form 10-Q ELI LILLY & Co For: Jun 30SEC filing · Form 10-Q+0.17%+1.59%
Lilly Confirms Date and Conference Call for Second-Quarter 2024 Financial Results AnnouncementPress release-0.65%-1.07%
Lilly Declares Third-Quarter 2024 DividendPress release-0.07%-0.79%
Lilly Declares Second-Quarter 2024 DividendPress release-0.09%+2.13%
Form 10-Q ELI LILLY & Co For: Mar 31SEC filing · Form 10-Q-0.28%+0.91%
Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline MomentumPress release+1.24%+1.05%
Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results AnnouncementPress release+0.04%-0.40%
Form 10-K ELI LILLY & Co For: Dec 31SEC filing · Form 10-K+0.07%+0.37%
Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 GuidancePress release-1.69%-4.47%
Lilly Confirms Date and Conference Call for Fourth-Quarter 2023 Financial Results and 2024 Financial GuidancePress release-0.11%+1.96%
Lilly Announces 15% Dividend Increase, First-Quarter 2024 DividendPress release+0.25%+2.11%
Form 10-Q ELI LILLY & Co For: Sep 30SEC filing · Form 10-Q-0.09%+0.48%
Lilly Reports Third-Quarter 2023 Financial Results, Highlights Strong Sales Growth and Business Development ActivityPress release+1.43%+0.26%
Lilly Declares Fourth-Quarter 2023 DividendPress release-0.04%-0.10%
Lilly Confirms Date and Conference Call for Third-Quarter 2023 Financial Results AnnouncementPress release-0.41%-1.13%
That’s how LLY usually reacts to earnings — get an email when it moves on news →
Keep exploring

More LLY: analyst actions → · SEC filings → · LLY overview →

Other Health Care names and their earnings

TickerEventsMedian 30-min% positive
Johnson & Johnson (JNJ)2,000++0.06%56%
UnitedHealth Group (UNH)2,000+-0.03%48%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.